Development of a Mucin4-targeting SPIO contrast agent for effective detection of pancreatic tumor cells in vitro and in vivo

Journal of Medicinal Chemistry

Volumn 56, Issue 22, 2013, Pages 9100-9109

  Wu, Shou Cheng ^a   Chen, Yu Jen ^a   Lin, Yi Jan ^b   Wu, Tung Ho ^c   Wang, Yun Ming ^a,b  

^a NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

MUCIN 4; SILANE DERIVATIVE; SUPERPARAMAGNETIC IRON OXIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER DIAGNOSIS; CONJUGATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FLUORESCENCE IMAGING; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; PROTEIN EXPRESSION; TUMOR CELL CULTURE;

ANIMALS; CELL LINE, TUMOR; CONTRAST MEDIA; DRUG DISCOVERY; FEMALE; FERRIC COMPOUNDS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETS; MICE; MUCIN-4; NANOPARTICLES; OPTICAL IMAGING; PANCREATIC NEOPLASMS; POLYETHYLENE GLYCOLS; SILANES;

EID: 84889264105     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm401060z     Document Type: Article

References (29)

1. Accardoa, A.; Gianoliob, E.; Arenab, F.; Barnertc, S.; Schubertc, R.; Tesauroa, D.; Morelli, G. Nanostructures based on monoolein or diolein and amphiphilic gadolinium complexes as MRI contrast agents J. Mater. Chem., B 2013, 1, 617-628
2. Laurent, S.; Forge, D.; Port, M.; Roch, A.; Robic, C.; Vander, E. L.; Muller, R. N. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications Chem. Rev. 2008, 108, 2064-2110
3. Wu, Y. L.; Ye, Q.; Ho, C. Cellular and functional imaging of cardiac transplant rejection Curr. Cardiovasc. Imaging Rep. 2011, 4, 50-62
4. Kuzucan, A.; Chen, J. H.; Bahri, S.; Mehta, R. S.; Carpenter, P. M.; Fwu, P. T.; Yu, H. J.; Hsiang, D. J.; Lane, K. T.; Butler, J. A.; Feig, S. A.; Su, M. Y. Diagnostic performance of magnetic resonance imaging for assessing tumor response in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy is associated with molecular biomarker profile Clin. Breast Cancer 2012, 12, 110-118
5. Ferrari, M. Cancer nanotechnology: opportunities and challenges Nature Rev. Cancer 2005, 5, 161-171 (Pubitemid 40314948)
6. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Thun, M. J. Cancer statistics 2009 CA, Cancer J. Clin. 2009, 59, 225-249
7. Liu, Z.; Peng, P. Inorganic nanomaterials for tumor angiogenesis imaging Eur. J. Nucl. Med. Mol. Imaging 2010, 37, 147-163
8. Yezhelyev, M.; Yacoub, R.; O'Regan, R. Inorganic nanoparticles for predictive oncology of breast cancer Nanomedicine 2009, 4, 83-103
9. Kang, H.; DeLong, R.; Fisher, M. H.; Juliano, R. L. Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides Pharm. Res. 2005, 22, 2099-2106 (Pubitemid 41821589)
10. Zhang, B.; Gong, X.; Hao, L.; Cheng, J.; Han, Y.; Chang, J. A novel method to enhance quantum yield of silica-coated quantum dots for biodetection Nanotechnology 2008, 19, 465604
11. Cheng, S. H.; Lee, C. H.; Yang, C. S.; Tseng, F. G.; Mou, C. Y.; Lo, L. W. Mesoporous silica nanoparticles functionalized with an oxygen sensing probe for cell photodynamic therapy: potential cancer theranostics J. Mater. Chem. 2009, 19, 1252-1257
12. Das, M.; Mohanty, C.; Sahoo, S. K. Ligand-based targeted therapy for cancer tissue Expet. Opin. Drug Delivery 2009, 6, 285-304
13. Porchet, N.; Nguyen, V. C.; Dufosse, J.; Audie, J. P.; Guyonnet-Duperat, V.; Gross, M. S.; Denis, C.; Degand, P.; Bernheim, A.; Aubert, J. P. Molecular cloning and chromosomal localization of a novel human trachea-bronchial mucin cDNA containing tandemly repeated sequences of 48 base pairs Biochem. Biophys. Res. Commun. 1991, 175, 414-422
14. Andrianifahanana, M.; Moniaux, N.; Schmied, B. M.; Ringel, J.; Friess, H.; Hollingsworth, M. A.; Buchler, M. W.; Aubert, J. P.; Batra, S. K. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance Clin. Cancer Res. 2001, 7, 4033-4040 (Pubitemid 34044624)
15. Swartz, M. J.; Batra, S. K.; Varshney, G. C.; Hollingsworth, M. A.; Yeo, C. J.; Cameron, J. L.; Wilentz, R. E.; Hruban, R. H.; Argani, P. MUC4 expression increases progressively in pancreatic intraepithelial neoplasia Am. J. Clin. Pathol. 2002, 117, 791-796 (Pubitemid 34457016)
16. Singh, A. P.; Moniaux, N.; Chauhan, S. C.; Meza, J. L.; Batra, S. K. Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis Cancer Res. 2004, 64, 622-630 (Pubitemid 38120902)
17. Singh, A. P.; Chaturvedi, P.; Batra, S. K. Emerging roles of MUC4 in cancer: a novel target for diagnosis and therapy Cancer Res. 2007, 67, 433-436 (Pubitemid 46192176)
18. Jhala, N.; Jhala, D.; Vickers, S. M.; Eltoum, I.; Batra, S. K.; Manne, U.; Eloubeidi, M.; Jones, J. J.; Grizzle, W. E. Biomarkers in diagnosis of pancreatic carcinoma in fine-needle aspirates: a translational research application Am. J. Clin. Pathol. 2006, 126, 572-579 (Pubitemid 44498507)
19. Reimer, P.; Weissleder, R.; Shen, T.; Knoefel, W. T.; Brady, T. J. Pancreatic receptors: initial feasibility studies with a targeted contrast agent for MR imaging Radiology 1994, 193, 527-531 (Pubitemid 24338345)
20. Shen, T. T.; Bogdanov, A., Jr.; Bogdanova, A.; Poss, K.; Brady, T. J.; Weissleder, R. Magnetically labeled secretin retains receptor affinity to pancreas acinar cells Bioconjugate Chem. 1996, 7, 311-316 (Pubitemid 126639663)
21. Yang, L.; Mao, H.; Wang, Y. A.; Cao, Z.; Peng, X.; Wang, X.; Duan, H.; Ni, C.; Yuan, Q.; Adams, G.; Smith, M. Q.; Wood, W. C.; Gao, X.; Nie, S. Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging Small 2009, 5, 235-243
22. Montet, X.; Weissleder, R.; Josephson, L. Imaging pancreatic cancer with a peptide-nanoparticle conjugate targeted to normal pancreas Bioconjugate Chem. 2006, 17, 905-911 (Pubitemid 44162607)
23. Perrais, M.; Pigny, P.; Ducourouble, M. P.; Petitprez, D.; Porchet, N.; Aubert, J. P.; Van Seuningen, I. Characterization of human mucin gene MUC4 promoter: importance of growth factors and proinflammatory cytokines for its regulation in pancreatic cancer cells J. Biol. Chem. 2001, 276, 30923-30933
24. Deer, E. L.; González-Hernández, J.; Coursen, J. D.; Shea, J. E.; Ngatia, J.; Scaife, C. L.; Firpo, M. A.; Mulvihill, S. J. Phenotype and genotype of pancreatic cancer cell lines Pancreas 2010, 39, 425-435
25. Wu, S. C.; Lin, K. L.; Wang, T. P.; Tzou, S. C.; Singh, G.; Chen, M. H.; Cheng, T. L.; Chen, C. Y.; Liu, G. C.; Lee, T. W.; Hu, S. H.; Wang, Y. M. Imaging specificity of MR-optical imaging agents following the masking of surface charge by poly(ethylene glycol) Biomaterials 2013, 34, 4118-4127
26. Ban, N.; Escobar, C.; Garcia, R.; Hasel, K.; Day, J.; Greenwood, A.; McPherson, A. Crystal structure of an idiotype-anti-idiotype Fab complex Proc. Natl. Acad. Sci. U. S. A. 1994, 91, 1604-1608 (Pubitemid 24080253)
27. Price-Schiavi, S. A.; Jepson, S.; Li, P.; Arango, M.; Rudland, P. S.; Yee, L.; Carraway, K. L. Rat MUC4 (sialomucin complex) reduces binding of anti-Erbb2 antibodies to tumor cell surfaces, a potential mechanism for herceptin resistance Int. J. Cancer 2002, 99, 783-791 (Pubitemid 34575694)
28. Rachagani, S.; Torres, M. P.; Kumar, S.; Haridas, D.; Baine, M.; Macha, M. A.; Kaur, S.; Ponnusamy, M. P.; Dey, P.; Seshacharyulu, P.; Johansson, S. L.; Jain, M.; Wagner, K. U.; Batra, S. K. Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy J. Hematol. Oncol. 2012, 5, 68-79
29. Hilderbrand, S. A.; Kelly, K. A.; Weissleder, R.; Tung, C. H. Monofunctional near-infrared fluorochromes for imaging applications Bioconjugate Chem. 2005, 16, 1275-1281 (Pubitemid 41368131)